5/10
08:43 am
fbio
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates [Yahoo! Finance]
Low
Report
Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates [Yahoo! Finance]
4/23
08:12 am
fbio
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer [Yahoo! Finance]
Medium
Report
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer [Yahoo! Finance]
4/12
02:04 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
4/4
11:04 pm
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/28
04:19 pm
fbio
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/28
04:05 pm
fbio
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Low
Report
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
3/28
11:13 am
fbio
Mustang Bio stock climbs 9% amid drug development update [Seeking Alpha]
Medium
Report
Mustang Bio stock climbs 9% amid drug development update [Seeking Alpha]
3/22
08:40 am
fbio
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Low
Report
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/19
08:37 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $5.00 price target on the stock.
Low
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) is now covered by analysts at Alliance Global Partners. They set a "buy" rating and a $5.00 price target on the stock.
3/18
08:17 am
fbio
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors [Yahoo! Finance]
Medium
Report
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors [Yahoo! Finance]
3/15
08:00 am
fbio
Fortress Biotech, Inc. (NASDAQ: FBIO) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock.
High
Report
Fortress Biotech, Inc. (NASDAQ: FBIO) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock.
3/12
08:52 am
fbio
Fortress Biotech to Participate in 36th Annual ROTH Conference [Yahoo! Finance]
Medium
Report
Fortress Biotech to Participate in 36th Annual ROTH Conference [Yahoo! Finance]
3/12
08:30 am
fbio
Fortress Biotech to Participate in 36th Annual ROTH Conference
Medium
Report
Fortress Biotech to Participate in 36th Annual ROTH Conference
3/4
08:42 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease [Yahoo! Finance]
Medium
Report
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease [Yahoo! Finance]
3/4
08:30 am
fbio
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
High
Report
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
2/17
08:40 am
fbio
Insider Stock Buying Reaches US$3.06m On Fortress Biotech [Yahoo! Finance]
Medium
Report
Insider Stock Buying Reaches US$3.06m On Fortress Biotech [Yahoo! Finance]